Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature.

Petri, Camille R; Patell, Rushad; Batalini, Felipe; Rangachari, Deepa; Hallowell, Robert W

Petri, Camille R; Patell, Rushad; Batalini, Felipe; Rangachari, Deepa; Hallowell, Robert W.

Afiliação

Petri CR; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Patell R; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Batalini F; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Rangachari D; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Hallowell RW; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Respir Med Case Rep ; 27: 100834, 2019.

Article em En | MEDLINE | ID: mdl-31008047

Palavras-chave

Cytotoxic T-lymphocyte antigen-4, CTLA-4; Immune checkpoint inhibitor; Immune checkpoint inhibitor, ICI; Intravenous immunoglobulin; Intravenous immunoglobulin, IVIg; Pneumonitis; Programmed cell-death 1, PD-1; Programmed cell-death ligand, PD-L1; Pulmonary toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Respir Med Case Rep Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Respir Med Case Rep Ano de publicação: 2019 Tipo de documento: Article